Budget Amount *help |
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2018: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2017: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2016: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Outline of Final Research Achievements |
2-Hydroxypropyl-β-cyclodextrin (HP-β-CyD) extracts cholesterol from chronic myelogenous leukemia (CML) cells and may have antitumor effects not only on CML cells but also on CML stem cells. In the present study, we investigated the effects of HP-β-CyD on acute myeloid leukemia (AML). Anti-leukemic effect of folate-appended HP-β-CyD was also examined. AML cell line showed similar effect. In addition, folate-appended HP-β-CyD showed 10 to 20 times the antitumor activity of HP-β-CyD. Moreover, these actions are specific to folate receptor-expressing cells, and are considered to be promising as leukemia cell-targeted therapeutic agents.
|